|
全国免费电话：400-668-6834 -- 仅限中国地区 -- |
在线订购：QQ: 4006686834 电话订购：021-68591985 邮件订购：info@selleck.cn 我们也提供销售人员上门服务 |
技术支持电话：400-168-6834 我们将于一个工作日与您联系 |
Trastuzumab (anti-HER2)
目录号：A2007 批次号: A200706
Trastuzumab (anti-HER2)曲妥珠单抗是人源重组的抗体抑制剂，与HER2的胞外区域相结合。 MW:145.53 KD。
抗体信息
| CAS号 | 180288-69-1 |
|---|---|
| 配制 | 1×PBS, pH6.0 |
| 推荐同型对照 | Human IgG1 |
| 来源 | CHO cells |
| 储存条件 (自收到货起) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles |
| 纯度 | 99.84% |
| 蛋白浓度 | 3.27 mg/ml |
| 内毒素 | <1 EU/mg |
客户使用selleck产品的实验数据
.gif)
Trastuzumab (anti-HER2)在文献中得到引用
| CD70-targeted iPSC-derived CAR-NK cells display potent function against tumors and alloreactive T cells [ Cell Rep Med, 2025, 6(1):101889] | PubMed: 39793572 |
| Intracellular cartilage oligomeric matrix protein augments breast cancer resistance to chemotherapy [ Cell Death Dis, 2024, 15(7):480] | PubMed: 38965233 |
| Identification of a novel potent CDK inhibitor degrading cyclinK with a superb activity to reverse trastuzumab-resistance in HER2-positive breast cancer in vivo [ Eur J Med Chem, 2024, 264:116014] | PubMed: 38061230 |
| Additional statin treatment enhances the efficacy of HER2 blockade and improves prognosis in Rac1-high/HER2-positive breast cancer [ Biochim Biophys Acta Mol Basis Dis, 2024, 1870(8):167458] | PubMed: 39128642 |
| Induction of SUSD2 by STAT3 Activation Is Associated with Tumor Recurrence in HER2-Positive Breast Cancer [ Cells, 2024, 14(1)19] | PubMed: 39791720 |
| Trastuzumab Potentiates Antitumor Activity of Thiopyrano[2,3-d]Thiazole Derivative in AGS Gastric Cancer Cells [ Molecules, 2024, 29(21)5117] | PubMed: 39519758 |
| Investigation of ITGB3 Heterogeneity to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer [ Biology (Basel), 2024, 14(1)9] | PubMed: 39857240 |
| Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression [ Int J Biol Sci, 2023, 19(2):377-392] | PubMed: 36632463 |
| Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer [ Cell Death Dis, 2023, 14(8):532] | PubMed: 37596261 |
| Detecting Disruption of HER2 Membrane Protein Organization in Cell Membranes with Nanoscale Precision [ ACS Sens, 2023, 10.1021/acssensors.3c01437] | PubMed: 37955934 |
禁止用于人体及治疗！